Alta-innovations news

NewsRSS FeedAtom Feed

PsiOxus Therapeutics announces positive data in cancer-related cachexia clinical trial".

Description
Mid-Stage Clinical Study of wasting disease therapeutic MT-102 shows reversal of cancer related wasting.
Date:
13/11/2013

Alta Innovations completes new licence with Cytox

Description
Alta Innovations is pleased to announce it has entered into a new licence agreement with Cytox Limited, a University of Birmingham spinout company developing laboratory services for the in-vitro assessment of risk of dementias such as Alzheimer's disease.
Date:
26/09/2013

University of Birmingham launches Business Club

Description
Businesses from across the region recently visited Birmingham Research Park for an opportunity to network, be informed about funding opportunities available and learn how they can access the knowledge and expertise at the University of Birmingham.
Date:
13/09/2013

low cost agri-food diagnostic test to help prevent spread of crop disease

Description
Linear Diagnostics Ltd, Molecular Vision Ltd ("Molecular Vision") and the Food and Environment Research Council ("Fera"), are pleased to announce the award of a £392,000 grant from the UK's innovation agency, the Technology Strategy Board to help fund a two year project to develop an onsite, quick and simple diagnostic test for the detection of multiple pathogens in harvested crops.
Date:
03/09/2013

World's first point-of-care diagnostic device for multiple myeloma

Description
Serascience Limited, a specialist cancer diagnostics company established by a joint venture between Abingdon Health and the University of Birmingham, announces the receipt of European CE Mark approval for the commercial sale of Seralite, its proprietary point-of-care diagnostic device for multiple myeloma.
Date:
27/08/2013
Displaying 11 to 20 of 41